Back to top

Image: Bigstock

Canadian National (CNI) Achieves Record November Grain Shipment

Read MoreHide Full Article

Canadian National Railway Company (CNI - Free Report) achieved its new record in November by moving over 3 million metric tonnes (MMT) of Canadian grain for second month in a row. Canadian National moved in more than 3.12 MMT of Canadian grains in its previous month. This is followed by an all-time record of 3.27 MMT moved in October. Notably, November is the company’s ninth straight month of record grain movement.

Containerized grain is also setting records by moving 400,000 metric tonnes directly from western Canada. Owing to the upbeat grain movement, the company’s Grain and Fertilizers segment is likely to perform well in fourth-quarter 2020. In the September-end quarter, revenues in the Grain and Fertilizers segment increased 10%.

Upbeat grain movement is also benefitting another Canadian railroad operator, Canadian Pacific Railway Limited (CP - Free Report) . Evidently, Canadian Pacific transported 2.96 MMT of Canadian grain and grain products in November, up 8%.

Zacks Rank & Stocks to Consider

Canadian National currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader Zacks Transportation sector are Knight-Swift Transportation Holdings Inc. (KNX - Free Report) and Herc Holdings Inc. (HRI - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term expected earnings per share (three to five years) growth rate for Knight-Swift and Herc Holdings is pegged at 15% and 12.6%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

 

Published in